Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52)
NCT05049122
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Rhinosinusitis With Nasal Polyps
Interventions
DRUG:
Dupilumab SAR231893
Sponsor
Sanofi
Collaborators
[object Object]